DE602005002653D1 - Stabilisierte zusammensetzungen mit einem therapeutischen wirkstoff; zitronensäure oder einer konjugierten base und chlordioxid - Google Patents
Stabilisierte zusammensetzungen mit einem therapeutischen wirkstoff; zitronensäure oder einer konjugierten base und chlordioxidInfo
- Publication number
- DE602005002653D1 DE602005002653D1 DE602005002653T DE602005002653T DE602005002653D1 DE 602005002653 D1 DE602005002653 D1 DE 602005002653D1 DE 602005002653 T DE602005002653 T DE 602005002653T DE 602005002653 T DE602005002653 T DE 602005002653T DE 602005002653 D1 DE602005002653 D1 DE 602005002653D1
- Authority
- DE
- Germany
- Prior art keywords
- citric acid
- chlorine dioxide
- active substance
- therapeutic active
- conjugated base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 title abstract 6
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000004155 Chlorine dioxide Substances 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title abstract 2
- 235000019398 chlorine dioxide Nutrition 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/865,639 US20050276867A1 (en) | 2004-06-09 | 2004-06-09 | Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative |
US865639 | 2004-06-09 | ||
PCT/US2005/018026 WO2005123135A1 (en) | 2004-06-09 | 2005-05-19 | Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide |
Publications (2)
Publication Number | Publication Date |
---|---|
DE602005002653D1 true DE602005002653D1 (de) | 2007-11-08 |
DE602005002653T2 DE602005002653T2 (de) | 2008-07-17 |
Family
ID=34970420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005002653T Active DE602005002653T2 (de) | 2004-06-09 | 2005-05-19 | Stabilisierte zusammensetzungen mit einem therapeutischen wirkstoff; zitronensäure oder einer konjugierten base und chlordioxid |
Country Status (15)
Country | Link |
---|---|
US (4) | US20050276867A1 (de) |
EP (1) | EP1753461B1 (de) |
JP (1) | JP5108517B2 (de) |
KR (1) | KR101184166B1 (de) |
CN (1) | CN100579530C (de) |
AT (1) | ATE374043T1 (de) |
AU (1) | AU2005253931B2 (de) |
BR (1) | BRPI0511923A (de) |
CA (1) | CA2570148C (de) |
DE (1) | DE602005002653T2 (de) |
ES (1) | ES2289713T3 (de) |
HK (1) | HK1104212A1 (de) |
MX (1) | MXPA06014096A (de) |
NZ (1) | NZ589247A (de) |
WO (1) | WO2005123135A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9241918B2 (en) | 2005-03-16 | 2016-01-26 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US9561178B2 (en) * | 2006-07-25 | 2017-02-07 | Allergan, Inc. | Cyclosporin compositions |
US20100012892A1 (en) * | 2008-07-15 | 2010-01-21 | Basf Catalysts Llc | Tooth Whitening Compositions and Methods |
DE102009021372A1 (de) * | 2009-05-14 | 2010-11-18 | Ursapharm Arzneimittel Gmbh | Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung |
AU2010266539A1 (en) * | 2009-06-30 | 2012-01-19 | Allergan, Inc. | Pharmaceutical ophthalmological liquid compositions containing propionic acid derivatives as a preservative |
US20110136872A1 (en) * | 2009-12-09 | 2011-06-09 | Burk Robert M | Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
EP2714007A2 (de) * | 2011-05-27 | 2014-04-09 | Ratiopharm GmbH | Augenärztliche zubereitung mit einem pgf2alpha-analogon |
JP2013082682A (ja) * | 2011-09-29 | 2013-05-09 | Senju Pharmaceut Co Ltd | 亜塩素酸塩を含有する水性製剤 |
AU2012351948A1 (en) | 2011-12-16 | 2014-07-10 | Allergan, Inc. | Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer |
CN108310442B (zh) * | 2017-01-17 | 2021-08-27 | 台北科技大学 | 眼科用组合物 |
TW202014194A (zh) | 2018-04-27 | 2020-04-16 | 美商歐樂根公司 | 抗微生物功效增強且毒性降低之亞氯酸鈉組成物 |
US20220125801A1 (en) * | 2019-03-06 | 2022-04-28 | Mankind Pharma Ltd. | Ophthalmic composition of bimatoprost |
US10881111B1 (en) | 2019-11-26 | 2021-01-05 | NEOCL Co., Ltd. | Composition for providing room temperature long-term constant-concentration chlorine dioxide solution in aqueous medium and preparation method thereof |
US11786538B2 (en) | 2019-12-11 | 2023-10-17 | Somerset Therapeutics, Llc | Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties |
US20230293541A1 (en) | 2022-03-21 | 2023-09-21 | Somerset Therapeutics, Llc | Methods of treating ophthalmic conditions with enhanced penetration compositions of bimatoprost and timolol |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE578918A (de) * | 1958-06-11 | |||
US3278447A (en) * | 1963-12-02 | 1966-10-11 | Cloro Bac Products Inc | Process for stabilizing chlorine dioxide solution |
JPS60184002A (ja) * | 1984-03-01 | 1985-09-19 | Daiichi Seimo Kk | 赤腐れ菌又は青海苔の防除剤 |
US4689215A (en) * | 1984-07-30 | 1987-08-25 | Ratcliff Perry A | Method and composition for prevention and treatment of oral disease |
US4696811A (en) * | 1984-07-30 | 1987-09-29 | Ratcliff Perry A | Method and composition for prevention and treatment of oral disease |
JP2638611B2 (ja) | 1988-06-17 | 1997-08-06 | 紀久雄 及川 | 安定化二酸化塩素水溶液の製造法 |
CA2003198C (en) | 1988-11-29 | 1995-03-21 | Anthony J. Dziabo, Jr. | Aqueous ophthalmic solutions and method for preserving same |
WO1990006126A1 (en) | 1988-11-29 | 1990-06-14 | Bio-Cide International, Inc. | Disinfectant compositions for ophthalmic devices |
JPH02290240A (ja) * | 1989-04-28 | 1990-11-30 | Takasugi Seiyaku Kk | 凝固状環境浄化組成物 |
US5246662A (en) * | 1989-10-02 | 1993-09-21 | Allergan, Inc. | Methods for generating chlorine dioxide and compositions for disinfecting |
US5279673A (en) * | 1990-01-05 | 1994-01-18 | Allergan, Inc. | Methods to disinfect contact lenses |
JP2759538B2 (ja) * | 1990-01-24 | 1998-05-28 | 第一製薬株式会社 | マコンブ種苗の赤変病防除方法 |
JPH04349104A (ja) * | 1991-05-07 | 1992-12-03 | Takasugi Seiyaku Kk | 粉末又は粒状環境浄化組成物 |
US5736165A (en) | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
US5538974A (en) * | 1994-01-27 | 1996-07-23 | Senju Pharamceutical Co., Ltd. | Ophthalmic composition for lowering intraocular pressure |
JPH10211265A (ja) * | 1997-01-29 | 1998-08-11 | M Y Corp:Kk | 消臭・防腐・除菌作用を有する剤 |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
WO2002072105A2 (en) * | 2001-02-21 | 2002-09-19 | Alcon, Inc. | Improved prostanoid therapies for the treatment of glaucoma |
US6982079B2 (en) * | 2002-04-26 | 2006-01-03 | Allergan, Inc. | Compositions for treating hyperemia |
-
2004
- 2004-06-09 US US10/865,639 patent/US20050276867A1/en not_active Abandoned
-
2005
- 2005-05-19 MX MXPA06014096A patent/MXPA06014096A/es active IP Right Grant
- 2005-05-19 ES ES05752215T patent/ES2289713T3/es active Active
- 2005-05-19 WO PCT/US2005/018026 patent/WO2005123135A1/en active IP Right Grant
- 2005-05-19 AT AT05752215T patent/ATE374043T1/de active
- 2005-05-19 EP EP05752215A patent/EP1753461B1/de active Active
- 2005-05-19 AU AU2005253931A patent/AU2005253931B2/en active Active
- 2005-05-19 DE DE602005002653T patent/DE602005002653T2/de active Active
- 2005-05-19 US US11/570,200 patent/US8343949B2/en active Active
- 2005-05-19 NZ NZ589247A patent/NZ589247A/en not_active IP Right Cessation
- 2005-05-19 CA CA2570148A patent/CA2570148C/en active Active
- 2005-05-19 CN CN200580018817A patent/CN100579530C/zh not_active Expired - Fee Related
- 2005-05-19 BR BRPI0511923-5A patent/BRPI0511923A/pt not_active IP Right Cessation
- 2005-05-19 KR KR1020067025890A patent/KR101184166B1/ko not_active IP Right Cessation
- 2005-05-19 JP JP2007527544A patent/JP5108517B2/ja active Active
-
2007
- 2007-08-17 HK HK07108977A patent/HK1104212A1/xx not_active IP Right Cessation
-
2012
- 2012-11-30 US US13/690,863 patent/US8691802B2/en active Active
-
2014
- 2014-04-04 US US14/245,014 patent/US20150283240A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2570148A1 (en) | 2005-12-29 |
JP5108517B2 (ja) | 2012-12-26 |
WO2005123135A1 (en) | 2005-12-29 |
US8343949B2 (en) | 2013-01-01 |
HK1104212A1 (en) | 2008-01-11 |
ES2289713T3 (es) | 2008-02-01 |
AU2005253931B2 (en) | 2011-05-19 |
US20130090387A1 (en) | 2013-04-11 |
KR20070028405A (ko) | 2007-03-12 |
EP1753461B1 (de) | 2007-09-26 |
US20150283240A1 (en) | 2015-10-08 |
EP1753461A1 (de) | 2007-02-21 |
KR101184166B1 (ko) | 2012-09-19 |
CN100579530C (zh) | 2010-01-13 |
ATE374043T1 (de) | 2007-10-15 |
CN1964743A (zh) | 2007-05-16 |
MXPA06014096A (es) | 2007-01-31 |
US20080300315A1 (en) | 2008-12-04 |
US8691802B2 (en) | 2014-04-08 |
NZ589247A (en) | 2012-06-29 |
CA2570148C (en) | 2012-10-23 |
WO2005123135A8 (en) | 2006-06-22 |
BRPI0511923A (pt) | 2008-01-22 |
DE602005002653T2 (de) | 2008-07-17 |
JP2008502723A (ja) | 2008-01-31 |
AU2005253931A1 (en) | 2005-12-29 |
US20050276867A1 (en) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005002653D1 (de) | Stabilisierte zusammensetzungen mit einem therapeutischen wirkstoff; zitronensäure oder einer konjugierten base und chlordioxid | |
FIC20200014I1 (fi) | Fostamatinibi tai fostamatinibin farmaseuttisesti hyväksyttävä suola tai fostamatinibin hydraatti, solvaatti, tai N-oksidi, tai fostamatinibin farmaseuttisesti hyväksyttävä suola, erityisesti fostamatinibi dinatrium, valinnaisesti hydraatin muodossa | |
ATE514418T1 (de) | Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan | |
EA200700380A1 (ru) | Конъюгаты глицеринразветвлённого полиэтиленгликоля - гормона роста человека, способ их получения и способы их применения | |
NO20062198L (no) | Bradykinin B1 reseptorantagonister | |
DE60336664D1 (de) | Nichtnukleosidische reverse-transkriptase-hemmer | |
BRPI0418245A (pt) | nitróxi-derivados de prostaglandina | |
SV2005002099A (es) | " nuevos compuestos " ref. pc 32096a | |
DK1178958T3 (da) | N-cyanomethylamider som proteaseinhibitorer | |
CY1112478T1 (el) | Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες | |
ATE376832T1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
DE602004017194D1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
DK1256343T3 (da) | Flibanserin til behandlingen af extrapyramidale bevægelseslidelser | |
DK2249869T3 (da) | Flydende formulering af FSH | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
ATE477805T1 (de) | 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität | |
ATE369355T1 (de) | Pyrimidinamid derivate und deren verwendung | |
DE602005027231D1 (de) | Cylglycerolen und therapeutischen verwendungen derselben | |
SE0102440D0 (sv) | New compound | |
SE0401655D0 (sv) | New compounds | |
NO20051261L (no) | Morfin-6-glukuronidsalt | |
ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin | |
SE0001916D0 (sv) | Novel formulation | |
TNSN06113A1 (en) | Antagonists of the bradykinin b1 receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |